Cargando…
The evolving role of immuno‐oncology for the treatment of head and neck cancer
Monoclonal antibodies (mAbs) that target immune co‐signaling pathways have the potential to enable immune mediated tumor eradication. While early adoption of these agents for the treatment of advanced squamous cell carcinoma of the head and neck (SCCHN) has produced some astounding clinical successe...
Autores principales: | Strome, Arianna L., Zhang, Xiaoyu, Strome, Scott E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383301/ https://www.ncbi.nlm.nih.gov/pubmed/30828620 http://dx.doi.org/10.1002/lio2.235 |
Ejemplares similares
-
The role of vitamin D in head and neck cancer
por: Izreig, Said, et al.
Publicado: (2020) -
Head and neck cancer survivorship consensus statement from the American Head and Neck Society
por: Goyal, Neerav, et al.
Publicado: (2021) -
A laryngeal closure technique for the treatment of patients with head and neck cancer
por: Furukawa, Tatsuya, et al.
Publicado: (2019) -
Integrative care of the patient with head and neck cancer
por: Nguyen, Chau T., et al.
Publicado: (2018) -
The role of psycho-oncologic screenings in the detection and evaluation of depression in head and neck cancer aftercare patients
por: Hadas, Stefan, et al.
Publicado: (2021)